Dermatology
Partner With Us
Advertisement
Conexiant chevron_right Dermatology chevron_right New Study Explores COVID 19s Dermatologic Impact
From the Journals

New Study Explores COVID-19’s Dermatologic Impact

More than 20% of COVID-19 patients experience skin conditions, ranging from rashes to pseudochilblains, linked to immune response.

Conexiant
article Full Article subject Summary summarize Notecard
  1. SARS-CoV-2 infections have complex relationships with skin manifestations, revealing acute and long-term dermatologic impacts.
  2. The study in Journal of Investigative Dermatology examines the prevalence, clinical characteristics, and immunopathogenic mechanisms of skin conditions during COVID-19 infections and post-COVID conditions.
  3. Over 20% of patients with acute COVID-19 infections exhibit cutaneous involvement, with conditions varying across COVID-19 waves.
  4. Pseudochilblains, often seen in asymptomatic or mild cases, have distinct immunologic pathways. 
  5. Post-COVID conditions may involve chronic inflammatory responses triggered by lingering viral antigens or immune dysregulation.

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.